Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America
This issue addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. New anticoagulants discussed include oral Xa inhibitors, oral IIa inhibitors, agents for the...
Leider schon ausverkauft
116.99 €
versandkostenfrei
Produktdetails
Produktinformationen zu „Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America “
Weitere Produktinformationen zu „Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America “
This issue addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. New anticoagulants discussed include oral Xa inhibitors, oral IIa inhibitors, agents for the treatment of HIT, and use of low molecular weight heparin to improve survival in cancer patients.
Bibliographische Angaben
- Autoren: Mark Crowther , Marco Donadini
- Verlag: ELSEVIER HEALTH SCIENCE
- EAN: 9781437725292
Kommentar zu "Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America"
0 Gebrauchte Artikel zu „Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America".
Kommentar verfassen